Pcn239 - Nice and the Cancer Drugs Fund: Appraising Treatments for Rarer Cancers in England

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.321
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

PCN163 Funding by SHAs for Rarer Cancers in England: Key Success Factors in the Uptake of Cancer Drugs Fund

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Pcn305 - Nice and the Cancer Drugs Fund – Can Observational Evidence Inform Funding Decisions in Oncology?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Potential Impact of the Cancer Drugs Fund Reform on Orphan Cancers

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Pcn302 - Is the New Nice Appraisal Process for Oncology Indications Too Positive in Its Assessment of Cancer Drugs in England?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pcn43 - A Targeted Review of Nice Single Technology Appraisals (Stas) in Urothelial Cancer Since the Introduction of the New Cancer Drugs Fund (Cdf)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cutbacks at England's Cancer Drugs Fund

Cancer Discovery
Oncology
2015English

Psy182 - A Targeted Review of Haematology Single Technology Appraisals (Stas) by Nice Since the Introduction of the New Cancer Drugs Fund (Cdf)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pcn288 - Has the New Nice Appraisal Process for Oncology Drugs Delivered Faster Patient Access to Innovative Treatments?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pcn319 - RCT Not Rwe: Two Year Report Card for the Cancer Drugs Fund Reforms

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy